Biopharma covers Ukraine’s need for blood products by 100%
Biopharma covers the demand of the domestic market for blood products by 100%, and can resume their export, Oksana Muliarchuk, director of the company’s plasma center network, said.
In addition, according to Maliarchuk, Biopharma began to restore the work of its plasma centers. So, for two months since the war started, plasma centers in Cherkasy and Sumy had been operating, which prepared only blood components. In early May 2022, the company resumed the work of plasma collection centers in Cherkasy and Kamianske and is launching the center in Sumy.